PHARMACOKINETICS OF I.M. GLYCOPYRRONIUM

A sensitive radioreceptor assay was used to determine the pharmacokinetics of glyco-pyrronium following a single i.m. injection of 8 ug kg−1 in nine surgical patients. Rapid absorption was found, with a mean peak plasma concentration after 16.1 min and mean elimination half-life of 75.4 min. Almost...

Full description

Saved in:
Bibliographic Details
Published in:British journal of anaesthesia : BJA 1990-06, Vol.64 (6), p.667-669
Main Authors: ALI-MELKKILÄ, T.M., KAILA, T., KANTO, J., IISALO, E.
Format: Article
Language:English
Subjects:
Biological and medical sciences
Blood Pressure - drug effects
Cholinergic system
Female
Glycopyrrolate - administration & dosage
Glycopyrrolate - blood
Glycopyrrolate - pharmacokinetics
Half-Life
Heart Rate - drug effects
Humans
Injections, Intramuscular
Medical sciences
Middle Aged
Neuropharmacology
Neurotransmitters. Neurotransmission. Receptors
Pharmacology. Drug treatments
Pyrrolidines - pharmacokinetics
Salivation - drug effects
Time Factors
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3547-8a844f255a25cd542be01bd3199de01a6380f34d0627055b8750aa3831f6555d3
cites
container_end_page 669
container_issue 6
container_start_page 667
container_title British journal of anaesthesia : BJA
container_volume 64
creator ALI-MELKKILÄ, T.M.
KAILA, T.
KANTO, J.
IISALO, E.
description A sensitive radioreceptor assay was used to determine the pharmacokinetics of glyco-pyrronium following a single i.m. injection of 8 ug kg−1 in nine surgical patients. Rapid absorption was found, with a mean peak plasma concentration after 16.1 min and mean elimination half-life of 75.4 min. Almost half (49.3%) of the drug was excreted in pharmacologically active form in the urine within 3 h. A significant increase in heart rate (P < 0.05) occurred in 15 min, lasting up to 60 min, and an antisialagogue effect in 10 min, lasting up to 8 h (P < 0.05). There was no measurable glycopyrronium in lumbar cerebrospinal fluid samples (n = 9) taken 40 min after administration of drug.
doi_str_mv 10.1093/bja/64.6.667
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79914111</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0007091217484868</els_id><sourcerecordid>79914111</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3547-8a844f255a25cd542be01bd3199de01a6380f34d0627055b8750aa3831f6555d3</originalsourceid><addsrcrecordid>eNptkEtPAjEURhujQUR3bk3YqBtnaKev6ZKMPCYCQxATddN0Op1kkJctGP33lkBw4-re5Dv57s0B4BrBEEGBW_lMtRgJWcgYPwF1RDgKGOfoFNQhhDyAAkXn4MK5GYSIR4LWQC3CPPZIHdyP--3JsJ1kT-moM02T52bWbabhMGz2Bm9JNn6bTLJR-jK8BGelmjtzdZgN8NLtTJN-MMh6adIeBBpTwoNYxYSUEaUqorqgJMoNRHmBkRCF3xTDMSwxKSCLOKQ0jzmFSuEYo5JRSgvcAHf73rVdfW6N28hF5bSZz9XSrLZOciEQQQh58GEPartyzppSrm21UPZHIih3XqT3IhmRTHovHr859G7zhSmO8EGEz28PuXJazUurlrpyf52CCojjHRfsucptzPcxV_ZD-iucyv7ru3x8FRP6jrlMPM_2vPHSvipjpdOVWWpTVNbojSxW1f8P_wL7LIYG</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79914111</pqid></control><display><type>article</type><title>PHARMACOKINETICS OF I.M. GLYCOPYRRONIUM</title><source>Oxford University Press:Jisc Collections:Oxford Journal Archive: Access period 2024-2025</source><creator>ALI-MELKKILÄ, T.M. ; KAILA, T. ; KANTO, J. ; IISALO, E.</creator><creatorcontrib>ALI-MELKKILÄ, T.M. ; KAILA, T. ; KANTO, J. ; IISALO, E.</creatorcontrib><description>A sensitive radioreceptor assay was used to determine the pharmacokinetics of glyco-pyrronium following a single i.m. injection of 8 ug kg−1 in nine surgical patients. Rapid absorption was found, with a mean peak plasma concentration after 16.1 min and mean elimination half-life of 75.4 min. Almost half (49.3%) of the drug was excreted in pharmacologically active form in the urine within 3 h. A significant increase in heart rate (P &lt; 0.05) occurred in 15 min, lasting up to 60 min, and an antisialagogue effect in 10 min, lasting up to 8 h (P &lt; 0.05). There was no measurable glycopyrronium in lumbar cerebrospinal fluid samples (n = 9) taken 40 min after administration of drug.</description><identifier>ISSN: 0007-0912</identifier><identifier>EISSN: 1471-6771</identifier><identifier>DOI: 10.1093/bja/64.6.667</identifier><identifier>PMID: 2378771</identifier><identifier>CODEN: BJANAD</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Biological and medical sciences ; Blood Pressure - drug effects ; Cholinergic system ; Female ; Glycopyrrolate - administration &amp; dosage ; Glycopyrrolate - blood ; Glycopyrrolate - pharmacokinetics ; Half-Life ; Heart Rate - drug effects ; Humans ; Injections, Intramuscular ; Medical sciences ; Middle Aged ; Neuropharmacology ; Neurotransmitters. Neurotransmission. Receptors ; Pharmacology. Drug treatments ; Pyrrolidines - pharmacokinetics ; Salivation - drug effects ; Time Factors</subject><ispartof>British journal of anaesthesia : BJA, 1990-06, Vol.64 (6), p.667-669</ispartof><rights>1990</rights><rights>1991 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3547-8a844f255a25cd542be01bd3199de01a6380f34d0627055b8750aa3831f6555d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19590381$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2378771$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>ALI-MELKKILÄ, T.M.</creatorcontrib><creatorcontrib>KAILA, T.</creatorcontrib><creatorcontrib>KANTO, J.</creatorcontrib><creatorcontrib>IISALO, E.</creatorcontrib><title>PHARMACOKINETICS OF I.M. GLYCOPYRRONIUM</title><title>British journal of anaesthesia : BJA</title><addtitle>Br J Anaesth</addtitle><description>A sensitive radioreceptor assay was used to determine the pharmacokinetics of glyco-pyrronium following a single i.m. injection of 8 ug kg−1 in nine surgical patients. Rapid absorption was found, with a mean peak plasma concentration after 16.1 min and mean elimination half-life of 75.4 min. Almost half (49.3%) of the drug was excreted in pharmacologically active form in the urine within 3 h. A significant increase in heart rate (P &lt; 0.05) occurred in 15 min, lasting up to 60 min, and an antisialagogue effect in 10 min, lasting up to 8 h (P &lt; 0.05). There was no measurable glycopyrronium in lumbar cerebrospinal fluid samples (n = 9) taken 40 min after administration of drug.</description><subject>Biological and medical sciences</subject><subject>Blood Pressure - drug effects</subject><subject>Cholinergic system</subject><subject>Female</subject><subject>Glycopyrrolate - administration &amp; dosage</subject><subject>Glycopyrrolate - blood</subject><subject>Glycopyrrolate - pharmacokinetics</subject><subject>Half-Life</subject><subject>Heart Rate - drug effects</subject><subject>Humans</subject><subject>Injections, Intramuscular</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neuropharmacology</subject><subject>Neurotransmitters. Neurotransmission. Receptors</subject><subject>Pharmacology. Drug treatments</subject><subject>Pyrrolidines - pharmacokinetics</subject><subject>Salivation - drug effects</subject><subject>Time Factors</subject><issn>0007-0912</issn><issn>1471-6771</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1990</creationdate><recordtype>article</recordtype><recordid>eNptkEtPAjEURhujQUR3bk3YqBtnaKev6ZKMPCYCQxATddN0Op1kkJctGP33lkBw4-re5Dv57s0B4BrBEEGBW_lMtRgJWcgYPwF1RDgKGOfoFNQhhDyAAkXn4MK5GYSIR4LWQC3CPPZIHdyP--3JsJ1kT-moM02T52bWbabhMGz2Bm9JNn6bTLJR-jK8BGelmjtzdZgN8NLtTJN-MMh6adIeBBpTwoNYxYSUEaUqorqgJMoNRHmBkRCF3xTDMSwxKSCLOKQ0jzmFSuEYo5JRSgvcAHf73rVdfW6N28hF5bSZz9XSrLZOciEQQQh58GEPartyzppSrm21UPZHIih3XqT3IhmRTHovHr859G7zhSmO8EGEz28PuXJazUurlrpyf52CCojjHRfsucptzPcxV_ZD-iucyv7ru3x8FRP6jrlMPM_2vPHSvipjpdOVWWpTVNbojSxW1f8P_wL7LIYG</recordid><startdate>199006</startdate><enddate>199006</enddate><creator>ALI-MELKKILÄ, T.M.</creator><creator>KAILA, T.</creator><creator>KANTO, J.</creator><creator>IISALO, E.</creator><general>Elsevier Ltd</general><general>Oxford University Press</general><scope>6I.</scope><scope>AAFTH</scope><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199006</creationdate><title>PHARMACOKINETICS OF I.M. GLYCOPYRRONIUM</title><author>ALI-MELKKILÄ, T.M. ; KAILA, T. ; KANTO, J. ; IISALO, E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3547-8a844f255a25cd542be01bd3199de01a6380f34d0627055b8750aa3831f6555d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1990</creationdate><topic>Biological and medical sciences</topic><topic>Blood Pressure - drug effects</topic><topic>Cholinergic system</topic><topic>Female</topic><topic>Glycopyrrolate - administration &amp; dosage</topic><topic>Glycopyrrolate - blood</topic><topic>Glycopyrrolate - pharmacokinetics</topic><topic>Half-Life</topic><topic>Heart Rate - drug effects</topic><topic>Humans</topic><topic>Injections, Intramuscular</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neuropharmacology</topic><topic>Neurotransmitters. Neurotransmission. Receptors</topic><topic>Pharmacology. Drug treatments</topic><topic>Pyrrolidines - pharmacokinetics</topic><topic>Salivation - drug effects</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ALI-MELKKILÄ, T.M.</creatorcontrib><creatorcontrib>KAILA, T.</creatorcontrib><creatorcontrib>KANTO, J.</creatorcontrib><creatorcontrib>IISALO, E.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of anaesthesia : BJA</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ALI-MELKKILÄ, T.M.</au><au>KAILA, T.</au><au>KANTO, J.</au><au>IISALO, E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PHARMACOKINETICS OF I.M. GLYCOPYRRONIUM</atitle><jtitle>British journal of anaesthesia : BJA</jtitle><addtitle>Br J Anaesth</addtitle><date>1990-06</date><risdate>1990</risdate><volume>64</volume><issue>6</issue><spage>667</spage><epage>669</epage><pages>667-669</pages><issn>0007-0912</issn><eissn>1471-6771</eissn><coden>BJANAD</coden><abstract>A sensitive radioreceptor assay was used to determine the pharmacokinetics of glyco-pyrronium following a single i.m. injection of 8 ug kg−1 in nine surgical patients. Rapid absorption was found, with a mean peak plasma concentration after 16.1 min and mean elimination half-life of 75.4 min. Almost half (49.3%) of the drug was excreted in pharmacologically active form in the urine within 3 h. A significant increase in heart rate (P &lt; 0.05) occurred in 15 min, lasting up to 60 min, and an antisialagogue effect in 10 min, lasting up to 8 h (P &lt; 0.05). There was no measurable glycopyrronium in lumbar cerebrospinal fluid samples (n = 9) taken 40 min after administration of drug.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>2378771</pmid><doi>10.1093/bja/64.6.667</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-0912
ispartof British journal of anaesthesia : BJA, 1990-06, Vol.64 (6), p.667-669
issn 0007-0912
1471-6771
language eng
recordid cdi_proquest_miscellaneous_79914111
source Oxford University Press:Jisc Collections:Oxford Journal Archive: Access period 2024-2025
subjects Biological and medical sciences
Blood Pressure - drug effects
Cholinergic system
Female
Glycopyrrolate - administration & dosage
Glycopyrrolate - blood
Glycopyrrolate - pharmacokinetics
Half-Life
Heart Rate - drug effects
Humans
Injections, Intramuscular
Medical sciences
Middle Aged
Neuropharmacology
Neurotransmitters. Neurotransmission. Receptors
Pharmacology. Drug treatments
Pyrrolidines - pharmacokinetics
Salivation - drug effects
Time Factors
title PHARMACOKINETICS OF I.M. GLYCOPYRRONIUM
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T06%3A17%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PHARMACOKINETICS%20OF%20I.M.%20GLYCOPYRRONIUM&rft.jtitle=British%20journal%20of%20anaesthesia%20:%20BJA&rft.au=ALI-MELKKIL%C3%84,%20T.M.&rft.date=1990-06&rft.volume=64&rft.issue=6&rft.spage=667&rft.epage=669&rft.pages=667-669&rft.issn=0007-0912&rft.eissn=1471-6771&rft.coden=BJANAD&rft_id=info:doi/10.1093/bja/64.6.667&rft_dat=%3Cproquest_cross%3E79914111%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3547-8a844f255a25cd542be01bd3199de01a6380f34d0627055b8750aa3831f6555d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=79914111&rft_id=info:pmid/2378771&rfr_iscdi=true